New lead elements for histamine H3 receptor ligands in the pyrrolo[2,3-d]pyrimidine class
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (17) , 2890-2893
Abstract
No abstract availableKeywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico (3150198, 1161816)
This publication has 15 references indexed in Scilit:
- Scaffold variations in amine warhead of histamine H3 receptor antagonistsDrug Discovery Today: Technologies, 2013
- Novel and highly potent histamine H3 receptor ligands. Part 3: An alcohol function to improve the pharmacokinetic profileBioorganic & Medicinal Chemistry Letters, 2013
- Fused bicycles as arylketone bioisosteres leading to potent, orally active thiadiazole H3 antagonistsBioorganic & Medicinal Chemistry Letters, 2012
- Synthesis and biological evaluation of some thio containing pyrrolo [2,3-d]Pyrimidine derivatives for their anti-inflammatory and anti-microbial activitiesEuropean Journal of Medicinal Chemistry, 2010
- Histamine H3and H4receptors as novel drug targetsExpert Opinion on Investigational Drugs, 2009
- BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical PharmacologyThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Histamine and its receptorsBritish Journal of Pharmacology, 2006
- 4-Phenoxypiperidines: Potent, Conformationally Restricted, Non-Imidazole Histamine H3 AntagonistsJournal of Medicinal Chemistry, 2005
- Coordination of Histamine H3 Receptor Antagonists with Human Adrenal Cytochrome P450 EnzymesPharmacology, 2002
- Novel pyrrolo[2,3-d]pyrimidine antifolates: synthesis and antitumor activitiesJournal of Medicinal Chemistry, 1991